Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension (APOLLO)


May 1, 2016

Clinical trial

Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study.

Weinreb RN, Scassellati Sforzolini B, Vittitow J, Liebmann J.

Ophthalmology. 2016 May;123(5):965-73.
Full text | Metrics.

Share This Article :

Updated on March 7th, 2022

Source Archive